Cargando…

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools

BACKGROUND: Several decision support tools have been developed to aid policymaking regarding the adoption of pneumococcal conjugate vaccine (PCV) into national pediatric immunization programs. The lack of critical appraisal of these tools makes it difficult for decision makers to understand and choo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaiyakunapruk, Nathorn, Somkrua, Ratchadaporn, Hutubessy, Raymond, Henao, Ana Maria, Hombach, Joachim, Melegaro, Alessia, Edmunds, John W, Beutels, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117724/ https://www.ncbi.nlm.nih.gov/pubmed/21569402 http://dx.doi.org/10.1186/1741-7015-9-53

Ejemplares similares

Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
por: Somkrua, Ratchadaporn, et al.
Publicado: (2011)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
por: Hutubessy, Raymond, et al.
Publicado: (2011)

Combining cost-effectiveness results into a single measurement: What is the value?: Authors response
por: Dilokthornsakul, Piyameth, et al.
Publicado: (2022)

WHO guide on the economic evaluation of influenza vaccination
por: Newall, Anthony T., et al.
Publicado: (2017)

Public Health Value of a Hypothetical Pneumococcal Conjugate Vaccine (PCV) Introduction: A Case Study
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2022)

Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review
por: Patikorn, Chanthawat, et al.
Publicado: (2023)

Rationale and opportunities in estimating the economic burden of seasonal influenza across countries using a standardized WHO tool and manual
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2017)

Economic evaluation of seasonal influenza vaccination in elderly and health workers: A systematic review and meta-analysis
por: Dilokthornsakul, Piyameth, et al.
Publicado: (2022)

Optimising Assessments of the Epidemiological Impact in the Netherlands of Paediatric Immunisation with 13-Valent Pneumococcal Conjugate Vaccine Using Dynamic Transmission Modelling
por: De Cao, Elisabetta, et al.
Publicado: (2014)

A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda
por: Ngabo, Fidèle, et al.
Publicado: (2015)

A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact Infections
por: Hoang, Thang, et al.
Publicado: (2019)

The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis
por: Le, Lan My, et al.
Publicado: (2022)

Scoping review of modelling studies assessing the impact of disruptions to essential health services during COVID-19
por: Veettil, Sajesh K, et al.
Publicado: (2023)

Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
por: Bakır, Mustafa, et al.
Publicado: (2012)

7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?
por: Choi, Yoon Hong, et al.
Publicado: (2011)

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
por: Mangen, Marie-Josée J., et al.
Publicado: (2015)

1738. Cost-Effectiveness Analysis of Infant Pneumococcal Vaccination with the 20-Valent Pneumococcal Conjugate in the US
por: Rozenbaum, Mark, et al.
Publicado: (2023)

Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia
por: Sundaram, Neisha, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
por: Saokaew, Surasak, et al.
Publicado: (2014)

Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment
por: Beatty, Mark E., et al.
Publicado: (2011)

Effects of medication adherence on hospitalizations and healthcare costs in patients with schizophrenia in Thailand
por: Dilokthornsakul, Piyameth, et al.
Publicado: (2016)

Healthcare resource utilisation pattern and costs associated with herpes simplex virus diagnosis and management: a systematic review
por: Lee, Shaun Wen Huey, et al.
Publicado: (2022)

Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru
por: Gomez, Jorge Alberto, et al.
Publicado: (2013)

Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom
por: Wilson, Michele, et al.
Publicado: (2023)

Predicting the impact of pneumococcal conjugate vaccine programme options in Vietnam
por: Le Polain De Waroux, Olivier, et al.
Publicado: (2018)

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2020)

Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models
por: Ahmed, Ali, et al.
Publicado: (2023)

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
por: Permsuwan, Unchalee, et al.
Publicado: (2016)

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
por: Earnshaw, Stephanie R, et al.
Publicado: (2012)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
por: Kim, Hye-Young, et al.
Publicado: (2020)

Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countries
por: Hutubessy, Raymond
Publicado: (2013)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population
por: Huang, Min, et al.
Publicado: (2023)

Social behavior and decision making in bacterial conjugation
por: Koraimann, Günther, et al.
Publicado: (2014)

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
por: Chen, Cynthia, et al.
Publicado: (2018)

The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities
por: Li, Yan, et al.
Publicado: (2021)

Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications
por: Pecenka, Clint, et al.
Publicado: (2021)

Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China
por: Shen, Kunling, et al.
Publicado: (2018)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
por: Perdrizet, Johnna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5l88ge4f6cgu1ilbvhjsbmfhif